(Q38082670)

28 August 2017

title

Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation (English)

1 reference

28 August 2017

0 references

0 references

Rituraj Niranjan

1

1 reference

28 August 2017

publication date

19 February 2013

1 reference

28 August 2017

published in

Molecular Neurobiology

1 reference

28 August 2017

volume

48

1 reference

28 August 2017

issue

3

1 reference

28 August 2017

page(s)

412-428

1 reference

Epidemiology of Alzheimer's Disease

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Alzheimer disease: amyloidogenesis, the presenilins and animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Alzheimer's disease and other dementing conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Alzheimer's disease and other dementing illnesses in a defined United States population: incidence rates and clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

The role of S100a9 in the pathogenesis of Alzheimer's disease: the therapeutic effects of S100a9 knockdown or knockout

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Immunopathogenesis of neurodegenerative diseases: current therapeutic models of neuroprotection with special reference to natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Amyloid beta peptide induces necrosis rather than apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Neuroinflammation in Alzheimer's disease wanes with age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Butyrylcholinesterase in the life cycle of amyloid plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Amyloid deposition as the central event in the aetiology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Abeta-induced BACE-1 cleaves N-terminal sequence of mPGES-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

WNT5A signaling contributes to Aβ-induced neuroinflammation and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Apoptosis is induced by beta-amyloid in cultured central nervous system neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Potentiation of beta-folding of beta-amyloid peptide 25-35 by aluminum salts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Glia as a therapeutic target: selective suppression of human amyloid-beta-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Hydrogen peroxide mediates amyloid beta protein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer's disease-like amyloid pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Upregulation of amyloid precursor protein messenger RNA in response to traumatic brain injury: an ovine head impact model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Decreased neuronal CD200 expression in IL-4-deficient mice results in increased neuroinflammation in response to lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Amyloid precursor protein gene isoforms in Alzheimer's disease and other neurodegenerative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Alzheimer's disease: a re-examination of the amyloid hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Alzheimer's disease and the amyloid beta protein: What is the role of amyloid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Reducing cerebral microvascular amyloid-beta protein deposition diminishes regional neuroinflammation in vasculotropic mutant amyloid precursor protein transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Progressive increase in infarct size, neuroinflammation, and cognitive deficits in the presence of high levels of amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Gray and white matter volume changes in early RRMS: a 2-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Phospholipases A2 mediate amyloid-beta peptide-induced mitochondrial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Targeting intracellular and extracellular alpha-synuclein as a therapeutic strategy in Parkinson's disease and other synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Development of a novel method for quantification of sterols and oxysterols by UPLC-ESI-HRMS: application to a neuroinflammation rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Mustard oil has differential effects on the response of trigeminal caudalis neurons to heat and acidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Mitochondrial cholesterol loading exacerbates amyloid beta peptide-induced inflammation and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Statins and the risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Somatostatin, tau, and beta-amyloid within the anterior olfactory nucleus in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Cholesterol-depleting statin drugs protect postmitotically differentiated human neurons against ethanol- and human immunodeficiency virus type 1-induced oxidative stress in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Altered brain lipid composition in cyclooxygenase-2 knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

How do statins control neuroinflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

ABCG1 influences the brain cholesterol biosynthetic pathway but does not affect amyloid precursor protein or apolipoprotein E metabolism in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

A pivotal role for interleukin-4 in atorvastatin-associated neuroprotection in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Neurosteroid-mediated regulation of brain innate immunity in HIV/AIDS: DHEA-S suppresses neurovirulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Inhibition of 26S protease regulatory subunit 7 (MSS1) suppresses neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Lipopolysaccharide-induced neuroinflammation leads to the accumulation of ubiquitinated proteins and increases susceptibility to neurodegeneration induced by proteasome inhibition in rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

On the mechanism of inhibition of p27 degradation by 15-deoxy-Delta12,14-prostaglandin J2 in lymphoblasts of Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

It may take inflammation, phosphorylation and ubiquitination to 'tangle' in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Role of the proteasome in Alzheimer’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Proteasome inhibition in neuronal cells induces a proinflammatory response manifested by upregulation of cyclooxygenase-2, its accumulation as ubiquitin conjugates, and production of the prostaglandin PGE(2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Melatonin as a potential therapeutic agent in psychiatric illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Inhibition of the ubiquitin-proteasome system in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Proteasome activity is critical for the cAMP-induced differentiation of neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Prostaglandin J2 alters pro-survival and pro-death gene expression patterns and 26 S proteasome assembly in human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Prostaglandins as putative neurotoxins in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Oxidative inactivation of the proteasome in retinal pigment epithelial cells. A potential link between oxidative stress and up-regulation of interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Interaction between interleukin-8 and methylenetetrahydrofolate reductase genes modulates Alzheimer's disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Oxidative stress in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Inflammatory regulation of ATP binding cassette efflux transporter expression and function in microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Guggulipid and nimesulide differentially regulated inflammatory genes mRNA expressions via inhibition of NF-kB and CHOP activation in LPS-stimulated rat astrocytoma cells, C6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Melatonin attenuated mediators of neuroinflammation and alpha-7 nicotinic acetylcholine receptor mRNA expression in lipopolysaccharide (LPS) stimulated rat astrocytoma cells, C6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Vitamin C reduces spatial learning deficits in middle-aged and very old APP/PSEN1 transgenic and wild-type mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Efficacy of a vitamin/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Chronic microglial activation and progressive dopaminergic neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Elevated cerebrospinal fluid levels of prostaglandin E2 and 15-(S)-hydroxyeicosatetraenoic acid in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Oxidative stress promotes JNK-dependent amyloidogenic processing of normally expressed human APP by differential modification of alpha-, beta- and gamma-secretase expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Dietary supplementation with α-tocopherol reduces neuroinflammation and neuronal degeneration in the rat brain after kainic acid-induced status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Oxidative stress induces macroautophagy of amyloid beta-protein and ensuing apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Intranasal tat alters gene expression in the mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Dietary supplementation with a combination of alpha-lipoic acid, acetyl-L-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain and improves cognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

The relation between inflammation and neurodegeneration in multiple sclerosis brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Epigenetics, oxidative stress, and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Oxidative Stress Signaling in Alzheimers Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Current and Future Therapeutic Strategies to Target Inflammation in Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

The Toll-->NFkappaB signaling pathway mediates the neuropathological effects of the human Alzheimer's Abeta42 polypeptide in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Melatonin attenuates kainic acid-induced hippocampal neurodegeneration and oxidative stress through microglial inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharide-activated primary rat microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Evaluation of guggulipid and nimesulide on production of inflammatory mediators and GFAP expression in LPS stimulated rat astrocytoma, cell line (C6).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

The effect of guggulipid and nimesulide on MPTP-induced mediators of neuroinflammation in rat astrocytoma cells, C6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Inflammatory mediator and beta-amyloid (25-35)-induced ceramide generation and iNOS expression are inhibited by vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Genetic risk factors in familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Interaction between the ADAM12 and SH3MD1 genes may confer susceptibility to late-onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Cloning and characterization of the presenilin-2 gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Genomic organization of the human amyloid beta-protein precursor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Nerve growth factor increases mRNA levels for the prion protein and the beta-amyloid protein precursor in developing hamster brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Transcriptional activation of Alzheimer's beta-amyloid precursor protein gene by stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Increased levels of the Kunitz protease inhibitor-containing beta APP mRNAs in rat brain following neurotoxic damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Increasing amyloid peptide precursor production and its impact on Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Distribution of precursor amyloid-beta-protein messenger RNA in human cerebral cortex: relationship to neurofibrillary tangles and neuritic plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Discovering statistically significant pathways in expression profiling studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Sp1 can displace GHF-1 from its distal binding site and stimulate transcription from the growth hormone gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Developmental expression of Sp1 in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Role of cyclooxygenase-2 induction by transcription factor Sp1 and Sp3 in neuronal oxidative and DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

SV40 stimulates expression of the transacting factor Sp1 at the mRNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Identification and characterization of a kappa B/Rel binding site in the regulatory region of the amyloid precursor protein gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Cyclooxygenase-1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Can NSAIDs contribute to Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Abeta 42 formation: not all NSAIDs are equal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

A role for presenilin in post-stress regulation: effects of presenilin mutations on Ca2+ currents in Drosophila.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Expression of presenilin-1 and -2 mRNAs in rat and Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Neuronal expression of STM2 mRNA in human brain is reduced in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Identification of caspases that cleave presenilin-1 and presenilin-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

The importance of inflammatory mechanisms in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Mutant presenilin 1 increases the expression and activity of BACE1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Genomic analysis of reactive astrogliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Regional brain activity of free radical defense enzymes in autopsy samples from patients with Alzheimer's disease and from nondemented controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

A hypothesis on the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Interleukin-6 receptor gene polymorphisms were associated with sporadic Alzheimer's disease in Chinese Han.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Variant of TREM2 Associated with the Risk of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

TREM2 Variants in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Mutations in TREM2 lead to pure early-onset dementia without bone cysts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Alzheimer's disease and rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Schizophrenia, Alzheimer's disease, and anti-inflammatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Complement activation by beta-amyloid in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Anti-inflammatory drugs and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Neuroinflammation and common mechanism in Alzheimer's disease and prion amyloidosis: amyloid-associated proteins, neuroinflammation and neurofibrillary degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Role of genes linked to sporadic Alzheimer's disease risk in the production of β-amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Enhanced HtrA2/Omi expression in oxidative injury to retinal pigment epithelial cells and murine models of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Lymphoid chemokines in chronic neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Anti-inflammatory effects of pioglitazone on iron-induced oxidative injury in the nigrostriatal dopaminergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

HtrA2 regulates beta-amyloid precursor protein (APP) metabolism through endoplasmic reticulum-associated degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

A new function of human HtrA2 as an amyloid-beta oligomerization inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

TbetaRI independently activates Smad- and CD2AP-dependent pathways in podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

The role of proteomics in dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Modulation of the Omi/HtrA2 signaling pathway after transient focal cerebral ischemia in mouse brains that overexpress SOD1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8428-4

Accumulation of intercellular adhesion molecule-1 in senile plaques in brain tissue of patients with Alzheimer's disease.

21 January 2018

1 reference

12 December 2020

Role of the proteasome in Alzheimer's disease

1 reference

12 December 2020

Identification of caspases that cleave presenilin-1 and presenilin-2. Five presenilin-1 (PS1) mutations do not alter the sensitivity of PS1 to caspases

1 reference

12 December 2020

Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease

1 reference

12 December 2020

Injury induces presenilin-1 gene expression in mouse brain.

1 reference

12 December 2020

Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease

1 reference

12 December 2020

Common variant in GAB2 is associated with late-onset Alzheimer's disease in Han Chinese.

1 reference

12 December 2020

Widespread neuronal expression of the presenilin-1 early-onset Alzheimer's disease gene in the murine brain

1 reference

12 December 2020

Inflammation and Alzheimer's disease

1 reference

12 December 2020

Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony

1 reference

12 December 2020

Inflammation as a pathogenic mechanism in Alzheimer's disease.

1 reference

12 December 2020

Neuroinflammatory changes increase the impact of stressors on neuronal function

1 reference

12 December 2020

Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues

1 reference

12 December 2020

4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimer's disease via regulation of β-secretase activity

1 reference

12 December 2020

Oxidative stress and neuroinflammation in Alzheimer's disease and amyotrophic lateral sclerosis: common links and potential therapeutic targets.

1 reference

12 December 2020

Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer's disease

1 reference

12 December 2020

Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood

1 reference

12 December 2020

Regulatory region of human amyloid precursor protein (APP) gene promotes neuron-specific gene expression in the CNS of transgenic mice.

1 reference

12 December 2020

Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes

1 reference

12 December 2020

Interactions between PPAR-α and inflammation-related cytokine genes on the development of Alzheimer's disease, observed by the Epistasis Project

1 reference

12 December 2020

Mitochondrial cholesterol in health and disease

1 reference

12 December 2020

Absence of TREM2 polymorphisms in patients with Alzheimer's disease and Frontotemporal Lobar Degeneration

1 reference

12 December 2020

Neuropathology and the neuroinflammation idea

1 reference

12 December 2020

Prostaglandins act as neurotoxin for differentiated neuroblastoma cells in culture and increase levels of ubiquitin and beta-amyloid

1 reference

12 December 2020

Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta-amyloid-induced toxicity in PC12 cells

1 reference

12 December 2020

The apolipoprotein gene family: organization of upstream elements and regulation of gene expression

1 reference

12 December 2020

Expression of beta-amyloid precursor protein in reactive astrocytes following neuronal damage

1 reference

12 December 2020

Microglia in Alzheimer's Disease: It's All About Context

1 reference

12 December 2020

Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo

1 reference

12 December 2020

Induction of beta-amyloid precursor protein isoform mRNAs by bFGF in astrocytes

1 reference

12 December 2020

Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins

1 reference

12 December 2020

Localization of the putative precursor of Alzheimer's disease-specific amyloid at nuclear envelopes of adult human muscle

1 reference

12 December 2020

Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro

1 reference

12 December 2020

A review: inflammatory process in Alzheimer's disease, role of cytokines.

1 reference

12 December 2020

Defective ubiquitination of cerebral proteins in Alzheimer's disease

1 reference

12 December 2020

Altered expression of amyloid precursors proteins after traumatic brain injury in rats: in situ hybridization and immunohistochemical study

1 reference

12 December 2020

Neuroinflammation: the world is not enough

1 reference

12 December 2020

Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro

1 reference

12 December 2020

The Seminal Role of β-Amyloid in the Pathogenesis of Alzheimer Disease

1 reference

12 December 2020

The pro region of human neutrophil defensin contains a motif that is essential for normal subcellular sorting.

1 reference

12 December 2020

Nimesulide limits kainate-induced oxidative damage in the rat hippocampus

1 reference

12 December 2020

Role of neuroinflammation in hypertension-induced brain amyloid pathology

1 reference

12 December 2020

10.1007/S12035-013-8428-4

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1018715037

0 references

1 reference